323 related articles for article (PubMed ID: 29558515)
1. New drug candidates for treatment of atypical meningiomas: An integrated approach using gene expression signatures for drug repurposing.
Zador Z; King AT; Geifman N
PLoS One; 2018; 13(3):e0194701. PubMed ID: 29558515
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of eIF4F components in meningiomas and suppression of meningioma cell growth by inhibiting translation initiation.
Oblinger JL; Burns SS; Huang J; Pan L; Ren Y; Shen R; Kinghorn AD; Welling DB; Chang LS
Exp Neurol; 2018 Jan; 299(Pt B):299-307. PubMed ID: 28610844
[TBL] [Abstract][Full Text] [Related]
3. Novel drug candidate for the treatment of several soft‑tissue sarcoma histologic subtypes: A computational method using survival‑associated gene signatures for drug repurposing.
Yang X; Huang WT; Wu HY; He RQ; Ma J; Liu AG; Chen G
Oncol Rep; 2019 Apr; 41(4):2241-2253. PubMed ID: 30816547
[TBL] [Abstract][Full Text] [Related]
4. Weighted gene co-expression network analysis and connectivity map identifies lovastatin as a treatment option of gastric cancer by inhibiting HDAC2.
Zhang L; Kang W; Lu X; Ma S; Dong L; Zou B
Gene; 2019 Jan; 681():15-25. PubMed ID: 30266498
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous analysis of miRNA-mRNA in human meningiomas by integrating transcriptome: A relationship between PTX3 and miR-29c.
Dalan AB; Gulluoglu S; Tuysuz EC; Kuskucu A; Yaltirik CK; Ozturk O; Ture U; Bayrak OF
BMC Cancer; 2017 Mar; 17(1):207. PubMed ID: 28327132
[TBL] [Abstract][Full Text] [Related]
6. Microarray-based gene expression profiling of benign, atypical and anaplastic meningiomas identifies novel genes associated with meningioma progression.
Wrobel G; Roerig P; Kokocinski F; Neben K; Hahn M; Reifenberger G; Lichter P
Int J Cancer; 2005 Mar; 114(2):249-56. PubMed ID: 15540215
[TBL] [Abstract][Full Text] [Related]
7. Novel drug candidates for treating esophageal carcinoma: A study on differentially expressed genes, using connectivity mapping and molecular docking.
Chen YT; Xie JY; Sun Q; Mo WJ
Int J Oncol; 2019 Jan; 54(1):152-166. PubMed ID: 30387840
[TBL] [Abstract][Full Text] [Related]
8. Comparative proteomic profiles of meningioma subtypes.
Okamoto H; Li J; Vortmeyer AO; Jaffe H; Lee YS; Gläsker S; Sohn TS; Zeng W; Ikejiri B; Proescholdt MA; Mayer C; Weil RJ; Oldfield EH; Zhuang Z
Cancer Res; 2006 Oct; 66(20):10199-204. PubMed ID: 17047085
[TBL] [Abstract][Full Text] [Related]
9. Computational Drug Repositioning for Gastric Cancer using Reversal Gene Expression Profiles.
Kim IW; Jang H; Kim JH; Kim MG; Kim S; Oh JM
Sci Rep; 2019 Feb; 9(1):2660. PubMed ID: 30804389
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiles of metabolic aggressiveness and tumor recurrence in benign meningioma.
Serna E; Morales JM; Mata M; Gonzalez-Darder J; San Miguel T; Gil-Benso R; Lopez-Gines C; Cerda-Nicolas M; Monleon D
PLoS One; 2013; 8(6):e67291. PubMed ID: 23840654
[TBL] [Abstract][Full Text] [Related]
11. Microarray gene expression profiling in meningiomas: differential expression according to grade or histopathological subtype.
Fèvre-Montange M; Champier J; Durand A; Wierinckx A; Honnorat J; Guyotat J; Jouvet A
Int J Oncol; 2009 Dec; 35(6):1395-407. PubMed ID: 19885562
[TBL] [Abstract][Full Text] [Related]
12. Integrated genomic analyses of de novo pathways underlying atypical meningiomas.
Harmancı AS; Youngblood MW; Clark VE; Coşkun S; Henegariu O; Duran D; Erson-Omay EZ; Kaulen LD; Lee TI; Abraham BJ; Simon M; Krischek B; Timmer M; Goldbrunner R; Omay SB; Baranoski J; Baran B; Carrión-Grant G; Bai H; Mishra-Gorur K; Schramm J; Moliterno J; Vortmeyer AO; Bilgüvar K; Yasuno K; Young RA; Günel M
Nat Commun; 2017 Feb; 8():14433. PubMed ID: 28195122
[TBL] [Abstract][Full Text] [Related]
13. Medical management of meningiomas.
Chukwueke UN; Wen PY
Handb Clin Neurol; 2020; 170():291-302. PubMed ID: 32586501
[TBL] [Abstract][Full Text] [Related]
14. In vitro testing to a panel of potential chemotherapeutics and current concepts of chemotherapy in benign meningiomas.
Balik V; Sulla I; Park HH; Sarissky M
Surg Oncol; 2015 Sep; 24(3):292-9. PubMed ID: 26099192
[TBL] [Abstract][Full Text] [Related]
15. Array expression meta-analysis of cancer stem cell genes identifies upregulation of PODXL especially in DCC low expression meningiomas.
Schulten HJ; Hussein D
PLoS One; 2019; 14(5):e0215452. PubMed ID: 31083655
[TBL] [Abstract][Full Text] [Related]
16. First insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation.
Dewan R; Pemov A; Dutra AS; Pak ED; Edwards NA; Ray-Chaudhury A; Hansen NF; Chandrasekharappa SC; Mullikin JC; Asthagiri AR; ; Heiss JD; Stewart DR; Germanwala AV
BMC Cancer; 2017 Feb; 17(1):127. PubMed ID: 28193203
[TBL] [Abstract][Full Text] [Related]
17. DNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrence.
Menghi F; Orzan FN; Eoli M; Farinotti M; Maderna E; Pisati F; Bianchessi D; Valletta L; Lodrini S; Galli G; Anghileri E; Pellegatta S; Pollo B; Finocchiaro G
Oncologist; 2011; 16(10):1440-50. PubMed ID: 21948653
[TBL] [Abstract][Full Text] [Related]
18. Differential expression profiling analyses identifies downregulation of 1p, 6q, and 14q genes and overexpression of 6p histone cluster 1 genes as markers of recurrence in meningiomas.
Pérez-Magán E; Rodríguez de Lope A; Ribalta T; Ruano Y; Campos-Martín Y; Pérez-Bautista G; García JF; García-Claver A; Fiaño C; Hernández-Moneo JL; Mollejo M; Meléndez B
Neuro Oncol; 2010 Dec; 12(12):1278-90. PubMed ID: 20685720
[TBL] [Abstract][Full Text] [Related]
19. SCNrank: spectral clustering for network-based ranking to reveal potential drug targets and its application in pancreatic ductal adenocarcinoma.
Liu E; Zhang ZZ; Cheng X; Liu X; Cheng L
BMC Med Genomics; 2020 Apr; 13(Suppl 5):50. PubMed ID: 32241274
[TBL] [Abstract][Full Text] [Related]
20. EPH receptor signaling as a novel therapeutic target in NF2-deficient meningioma.
Angus SP; Oblinger JL; Stuhlmiller TJ; DeSouza PA; Beauchamp RL; Witt L; Chen X; Jordan JT; Gilbert TSK; Stemmer-Rachamimov A; Gusella JF; Plotkin SR; Haggarty SJ; Chang LS; Johnson GL; Ramesh V;
Neuro Oncol; 2018 Aug; 20(9):1185-1196. PubMed ID: 29982664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]